Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-02-09 Stark David Matthew Exec. VP Chief Legal Officer Grant or award +52,774 68,286.39
2021-02-09 Stark David Matthew Exec. VP Chief Legal Officer Sale −12,538 $12.69 $159K 55,748.39
2021-02-09 Stark David Matthew Exec. VP Chief Legal Officer Sale −52,774 $12.69 $670K 2,974.39
2021-02-09 Stark David Matthew Exec. VP Chief Legal Officer Option exercise · Restricted Share Units −12,538 12,538
2021-02-09 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Restricted Share Units +37,884 37,884
2021-02-09 Schultz Kare President and CEO Option exercise +26,867 509,661
2021-02-09 Schultz Kare President and CEO Grant or award +226,173 735,834
2021-02-09 Schultz Kare President and CEO Option exercise · Restricted Share Units −26,867 26,867
2021-02-09 Sabag Mark See "Remarks" below Option exercise +15,523 40,273
2021-02-09 Sabag Mark See "Remarks" below Grant or award +65,339 105,612
2021-02-09 Sabag Mark See "Remarks" below Option exercise · Restricted Share Units −15,523 15,523
2021-02-09 Sabag Mark See "Remarks" below Grant or award · Restricted Share Units +37,884 37,884
2021-02-09 O'Grady Brendan P. EVP, North America Commercial Option exercise +16,120 30,988.49
2021-02-09 O'Grady Brendan P. EVP, North America Commercial Grant or award +67,852 98,840.49
2021-02-09 O'Grady Brendan P. EVP, North America Commercial Sale −3,974 $12.69 $50K 94,866.49
2021-02-09 O'Grady Brendan P. EVP, North America Commercial Sale −16,720 $12.69 $212K 78,146.49
2021-02-09 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −16,120 16,121
2021-02-09 Nazzi Gianfranco EVP, International Markets Option exercise +11,941 31,785.36
2021-02-09 Nazzi Gianfranco EVP, International Markets Grant or award +50,260 82,045.36
2021-02-09 Nazzi Gianfranco EVP, International Markets Sale −4,155 $12.72 $53K 77,890.36

Page 51 of 76 · 1,517 trades